Cargando…
Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation
Cisplatin-based chemotherapy remains the standard care for non-small cell lung cancer (NSCLC) patients. Relapse after chemotherapy-induced dormancy affects the overall survival of patients. The evolution of cancer cells under chemotherapy stress is regulated by transcription factors (TFs) with bindi...
Autores principales: | Wang, Lujuan, Peng, Qiu, Yin, Na, Xie, Yaohuan, Xu, Jiaqi, Chen, Anqi, Yi, Junqi, Tang, Jingqun, Xiang, Juanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413835/ https://www.ncbi.nlm.nih.gov/pubmed/34513309 http://dx.doi.org/10.1016/j.omtn.2021.07.019 |
Ejemplares similares
-
Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy
por: Wang, Lujuan, et al.
Publicado: (2022) -
Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
por: Xu, Jiaqi, et al.
Publicado: (2021) -
Exosomes from cisplatin-induced dormant cancer cells facilitate the formation of premetastatic niche in bone marrow through activating glycolysis of BMSCs
por: Xu, Jiaqi, et al.
Publicado: (2022) -
Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress
por: Dai, Yafei, et al.
Publicado: (2016) -
Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development
por: Zheng, Leliang, et al.
Publicado: (2020)